Pacer Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
4,478
-5,110
-53% -$1.74M ﹤0.01% 1065
2025
Q4
$3.81M Buy
+9,588
New +$4.24M 0.01% 810
2024
Q3
Sell
-461
Closed -$112K 2561
2024
Q2
$112K Buy
461
+176
+62% +$27.8K ﹤0.01% 2233
2024
Q1
$42.6K Buy
+285
New +$47.5K ﹤0.01% 3233
2021
Q2
Sell
-550
Closed -$78K 1409
2021
Q1
$78K Sell
550
-472
-46% -$71K ﹤0.01% 1326
2020
Q4
$133K Buy
1,022
+184
+22% +$24.6K ﹤0.01% 1312
2020
Q3
$122K Buy
+838
New +$119K ﹤0.01% 1233
2018
Q4
Sell
-2,640
Closed -$231K 553
2018
Q3
$231K Buy
+2,640
New +$266K 0.01% 1001
2018
Q1
Sell
-1,525
Closed -$194K 1042
2017
Q4
$194K Sell
1,525
-10,241
-87% -$1.29M 0.01% 908
2017
Q3
$1.38M Buy
11,766
+156
+1% +$13.3K 0.12% 158
2017
Q2
$926K Buy
11,610
+2,093
+22% +$134K 0.09% 274
2017
Q1
$488K Buy
9,517
+1,544
+19% +$71.4K 0.06% 494
2016
Q4
$299K Buy
7,973
+386
+5% +$16.2K 0.04% 694
2016
Q3
$514K Buy
7,587
+657
+9% +$46.4K 0.08% 353
2016
Q2
$385K Buy
6,930
+5,790
+508% +$365K 0.06% 451
2016
Q1
$72K Buy
1,140
+55
+5% +$3.66K 0.02% 712
2015
Q4
$102K Buy
+1,085
New +$101K 0.02% 580

Other funds holding ALNY